Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses S Elisaf

Showing results (61-70 of 198) with videos related to

Pageof 20
Sort By:
European Journal of Haematology|November 30, 2005
Alterations in electrolyte equilibrium in patients with acute leukemiaTheodosios D Filippatos, Haralampos J Milionis, Moses S Elisaf
Journal of Cardiovascular Pharmacology and Therapeutics|April 12, 2005
Evaluation of methods for the measurement of low-density lipoprotein cholesterolEleni T Bairaktari, Konstantin I Seferiadis, Moses S Elisaf
Current Pharmaceutical Design|October 8, 2003
The effects of lipid-regulating therapy on haemostatic parametersHaralampos J Milionis, Moses S Elisaf, Dimitri P Mikhailidis
Archives of Medical Sciences. Atherosclerotic Diseases|August 27, 2019
No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled studyMatilda Florentin, Evangelos Liberopoulos, Moses S Elisaf, et al.
Current Medical Research and Opinion|January 26, 2008
Lipid abnormalities and cardiovascular risk in the elderlyHaralampos J Milionis, Moses S Elisaf, Dimitri P Mikhailidis
Current Pharmaceutical Design|January 3, 2013
Pioglitazone and cancer: angel or demon?Michael S Kostapanos, Moses S Elisaf, Dimitri P Mikhailidis
Expert Opinion on Drug Metabolism & Toxicology|April 22, 2014
The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected]Theodosios D Filippatos, Vasilios G Athyros, Moses S Elisaf
Journal of Cardiovascular Pharmacology and Therapeutics|May 8, 2008
An overview of the extra-lipid effects of rosuvastatinMichael S Kostapanos, Haralampos J Milionis, Moses S Elisaf
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 29, 2010
Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemiaMichael S Kostapanos, Haralampos J Milionis, Moses S Elisaf
Current Vascular Pharmacology|January 14, 2012
Aliskiren in patients with diabetes: a systematic reviewEvangelos C Rizos, Aris P Agouridis, Moses S Elisaf
Pageof 20

Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
European Journal of Haematology|November 30, 2005
Alterations in electrolyte equilibrium in patients with acute leukemiaTheodosios D Filippatos, Haralampos J Milionis, Moses S Elisaf
Journal of Cardiovascular Pharmacology and Therapeutics|April 12, 2005
Evaluation of methods for the measurement of low-density lipoprotein cholesterolEleni T Bairaktari, Konstantin I Seferiadis, Moses S Elisaf
Current Pharmaceutical Design|October 8, 2003
The effects of lipid-regulating therapy on haemostatic parametersHaralampos J Milionis, Moses S Elisaf, Dimitri P Mikhailidis
Archives of Medical Sciences. Atherosclerotic Diseases|August 27, 2019
No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled studyMatilda Florentin, Evangelos Liberopoulos, Moses S Elisaf, et al.
Current Medical Research and Opinion|January 26, 2008
Lipid abnormalities and cardiovascular risk in the elderlyHaralampos J Milionis, Moses S Elisaf, Dimitri P Mikhailidis
Current Pharmaceutical Design|January 3, 2013
Pioglitazone and cancer: angel or demon?Michael S Kostapanos, Moses S Elisaf, Dimitri P Mikhailidis
Expert Opinion on Drug Metabolism & Toxicology|April 22, 2014
The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected]Theodosios D Filippatos, Vasilios G Athyros, Moses S Elisaf
Journal of Cardiovascular Pharmacology and Therapeutics|May 8, 2008
An overview of the extra-lipid effects of rosuvastatinMichael S Kostapanos, Haralampos J Milionis, Moses S Elisaf
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 29, 2010
Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemiaMichael S Kostapanos, Haralampos J Milionis, Moses S Elisaf
Current Vascular Pharmacology|January 14, 2012
Aliskiren in patients with diabetes: a systematic reviewEvangelos C Rizos, Aris P Agouridis, Moses S Elisaf
Pageof 20